Sabby Management’s China Pharma Holdings CPHI Stock Holding History

Sabby Management’s Portfolio CPHI Stock Details CPHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$203K	Buy	+308,360	New	+$325K	2.25%	15

Other funds holding CPHI

Jane Street New York $1.19T AUM 51.51% 1-Year Est. Return

StoneX Group New York $2.75B AUM 24.13% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Caitong International Asset Management Hong Kong $1.04B AUM 150.26% 1-Year Est. Return

Danske Bank Copenhagen K, Denmark $50.1B AUM 35.17% 1-Year Est. Return

Sabby Management's CPHI Position: Q3 2026 in Review

Sabby Management opened a new position in China Pharma Holdings (CPHI) in Q3 2026: 308,360 shares worth $203K. The stake represents 2.25% of the portfolio and ranks #15 among its holdings.

7 funds tracked by Wall St. Rank hold CPHI as of Q3 2026.

Sabby Management held 308,360 shares of China Pharma Holdings worth $203K as of Q3 2026.
China Pharma Holdings was a new Sabby Management position in Q3 2026.
China Pharma Holdings made up 2.25% of Sabby Management's portfolio in Q3 2026, its #15 holding.
7 funds tracked by Wall St. Rank held China Pharma Holdings as of Q3 2026.

Based on Sabby Management's 13F filing for Q3 2026, filed 13 Nov 2026.